S&P 500 7,704.13 −0.02%
Nasdaq 26,939.37 +0.01%
S&P/TSX 35,706.46 −0.13%
Apple 335.92 −0.33%
Nvidia 224.58 −0.41%
Microsoft 497.93 −0.53%
Shopify 205.30 +2.41%
Royal Bank 282.11 +0.27%
CAD/USD 0.7069 −0.29%
CLOSED · 23:55 ET
Market ClerkRecap
Thu Sep 24 · markets closed2 signals today167 insider buys this week · $225.2MCIRO short report next: Sep 30The week ahead

AKTS

Aktis Oncology, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
19.63
−0.09 −0.46%
USD · close Sep 24

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

177 SESSIONS · DAILY CLOSES
34272014Sep 23 · Chief Medical Officer sell $156KSep 23 · Chief Medical Officer sell $103KAug 13 · 10-Q filed (Q2 2026)Aug 13 · 10-Q filed (Q1 2026)Aug 13 · 10-Q filed (Q2 2025)Aug 13 · 10-Q filed (Q1 2025)JAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-24
Shorts (latest report): 3.2M short · −272K last period
Every line of the math
71PASS

Congress is trading it

No STOCK Act disclosure names AKTS.

Insider activity

ALL 2
DateInsiderTypeValue
Sep 23Chief Medical OfficerSell$156K
Sep 23Chief Medical OfficerSell$103K
Watch AKTS. Know when insiders buy.
One email the day a filing lands. Free.